Browsing: Mortality Risk
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for mortality risk analysis, commentary and insights.
For life settlement markets, earlier diagnosis of chronic diseases may reduce projected life expectancy, thereby influencing the expected duration of premium payments and the timing of policy maturities.
The total number of life insurance policies purchased in the life settlement industry’s secondary market grew 10.2% from 2,697 in 2024 to 2,972 in 2025, according to new data published by life settlement provider, Coventry.
Efforts to find treatments that slow or prevent Alzheimer’s disease are making good progress, but the complexities of tackling the illness…
Latest CMI model not likely to have material impact on pensions de-risking activity.
Fitch Ratings has a ‘neutral’ outlook for North American life insurers for 2026 despite a more challenging backdrop.
New policies that will fuel future trades in the life settlement market continue to be issued in healthy volumes, but in real terms, are slowly contracting.
In today’s rapidly evolving insurance landscape, the arrival of AI in Life and Health underwriting and claims workflows is no longer a distant possibility – it’s already a reality.
Griffith Ballard will continue to operate from Cedar Rapids under its existing leadership team.
The past 12 months have seen significant developments that are likely to shape mortality models among defined benefit pensions scheme managers and sponsors alike, and possibly even have an impact on the pricing of de-risking deals.
The broader consequences of climate change are complex and far-reaching, with significant implications for human health, financial systems and the wider economy.